ArticleFuture oncology (London, England)Published
Autologous cell immunotherapy (IGV-001) with IGF-1R antisense oligonucleotide in newly diagnosed glioblastoma patients
Regional connection
Verified An author affiliation on the Europe PMC record names Thomas Jefferson University. Affiliation source
- Institution
- Thomas Jefferson University
- County
- Philadelphia County
Publication record
- Type
- Article
- Venue
- Future oncology (London, England)
- Published
- Topic
- Clinical care
- Subject terms
- Humans; Glioblastoma; Brain Neoplasms; Oligonucleotides, Antisense; Antineoplastic Agents, Alkylating; Drug Combinations; Disease-Free Survival; Immunotherapy; Randomized Controlled Trials as Topic; Temozolomide; Radiation; Antisense
- PubMed ID
- 38060340
- Open access
- Yes, open
- Added to directory
- Source checked